Delivery Order SPE2DB22D9101-SPE2DB23FU7NT

Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DOD) awarded a $2,524.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562093566 BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The order is to be performed in Park Ridge, Illinois between September 7-8, 2023. The DLA supports military readiness by procuring, managing and distributing medical supplies and pharmaceuticals to military treatment facilities worldwide. This small order for BEYFORTUS syringes aligns with the agency's mission to ensure...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $7,573.50 to DMS Pharmaceutical Group Inc. to supply 100 mg/ml syringes of Beyfortus. The place of performance is Park Ridge, Illinois. The order period of performance is from September 14, 2023 through September 15, 2023. No additional details were provided regarding the original solicitation or whether this award is associated with a larger governmentwide acquisition contract vehicle. The funding agency, DLA,...
The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a firm fixed price delivery order valued at fifteen thousand one hundred forty-seven dollars to DMS Pharmaceutical Group Incorporated. The order is for 4562251944 BEYFORTUS 100 MG/ML SYRINGEML and calls for delivery to a location in Park Ridge, Illinois between September 20th and 21st, 2023. No additional details were provided regarding the original solicitation, use of a contract vehicle, or...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $7,573.50 to DMS Pharmaceutical Group Inc. to supply 100 MG/ML syringes of Beyfortus. The place of performance is Park Ridge, Illinois. The order period of performance is from September 7-8, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle. The funding agency, DLA,...
The Defense Logistics Agency awarded a $10,098 delivery order to DMS Pharmaceutical Group Inc. to supply 4562264029 BEYFORTUS 100 MG/ML SYRINGEML. The firm fixed price order is being funded by the Department of Defense to supply the specified pharmaceutical product for use in DLA programs. Performance will take place at the prime contractor's facility located in Park Ridge, Illinois over a period of one day from September 21 through September 22, 2023. No subcontractors or set aside designations...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at eighty-eight thousand seven hundred twenty-seven dollars and seventy-three cents ($88,727.73) to DMS Pharmaceutical Group Incorporated. The order is for four hundred fifty-six thousand two hundred thirty-four thousand six hundred nineteen (4562344619) units of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to be delivered to a...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at two million five hundred twenty-four thousand five hundred dollars to DMS Pharmaceutical Group Incorporated. The order is for 4562251278 BEYFORTUS 100 MG/ML SYRINGEML to be delivered to a location in Park Ridge, Illinois between September 15th and 18th, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and its delivery orders support procurement of...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $36,215.40 to supply 50 MG/0.5 ML syringes of Beyfortus. The order has a firm fixed price and is for delivery to a location in Park Ridge, Illinois by October 18, 2023. No set-aside designation was used for this award placed against an unspecified agency-wide contract vehicle. The Defense Logistics Agency manages the global supply chain for the United States military and supports its readiness...
The Defense Logistics Agency Troop Support Medical awarded a $7,243.12 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562413573 units of Beyfortus 50 MG/0.5 ML syringes to be delivered by October 10, 2023. No set-aside designation was applied to this procurement. The Defense Logistics Agency supports the medical readiness of armed forces around the world by procuring pharmaceuticals and medical supplies, among other responsibilities....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-four thousand three hundred twenty-three dollars and ten cents ($54,323.10) to DMS Pharmaceutical Group Inc. to supply 4562345067 BEYFORTUS 100 MG/ML SYRINGEML. The place of performance will be Park Ridge, Illinois from September 27, 2023 through September 28, 2023. As a component of the Department of Defense, the Defense Logistics Agency supports America's armed forces by delivering critical supplies,...
  • SPE2DB22D9101
    Indefinite Delivery Contract
  • SPE2DB22D9101-SPE2DB23FU7NT
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty thousand one hundred ninety-six dollars to DMS Pharmaceutical Group Inc. to supply fifty thousand units of Beyfortus 50 MG/0.5 ML pre-filled syringes. Performance will take place in Park Ridge, Illinois over a one day period in September 2023. The DLA procures pharmaceuticals and medical supplies to support all branches of the U.S. military through various multiple award contracts. This delivery order was issued against an existing DLA pharmaceutical schedule to fulfill immediate requirements for a pediatric vaccine, with no subcontractors or set aside designations indicated.

Generated 12/23/23, 3:48 PM